Clinical Scorecard: Why Copilots Failed in R&D and What Comes Next

At a Glance

Key Highlights

• AI tools have limited impact on core scientific work due to inadequate design for scientific standards.
• Trust in R&D relies on traceability and the ability to interrogate reasoning.
• Fragmentation occurs when tools address narrow tasks without a shared system.
• The shift is towards systems owning segments of workflows rather than just supporting individual tasks.
• Successful organizations will align technology with scientific realities and prioritize output quality.
• Continuous evaluation of AI systems is crucial for maintaining trustworthiness.

Guideline-Based Recommendations

Diagnosis

• Assess the limitations of current AI tools in meeting scientific standards.

Management

• Focus on building systems that enhance transparency and evaluability in research.
• Foster collaboration between R&D leadership and IT to align productivity goals.

Monitoring & Follow-up

• Continuously evaluate AI systems for their ability to produce trustworthy outputs.

Risks

• Avoid reliance on isolated tools that do not integrate into broader research workflows.

Patient & Prescribing Data

Not applicable; focuses on research organizations rather than patients.

Emphasize the need for AI systems that support scientific reasoning and decision-making.

Clinical Best Practices

• Integrate AI tools that enhance scientific reasoning and evidence evaluation.
• Ensure continuous iteration and adaptation of AI systems to keep pace with technological advancements.
• Foster collaboration between R&D leadership and IT to align productivity goals.

References